In this GEN webinar, experts from Perceptive Imaging and Flywheel explore how imaging data access issues slow decision-making and increase risks for both biopharma and CROs.
Optimising RSV sample handling and laboratory workflows to support faster, more efficient clinical trial delivery.
5don MSN
Insurance data can help fill gaps between longer medical trials for patients up against the clock
Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...
Jo Varshney, PhD, DVM, discusses how VeriSIM Life’s innovative approach leverages artificial intelligence and multispecies ...
NextTrial today announced the official launch of NextTrial One, a unified intelligence platform for life sciences designed to accelerate innovation and data-driven decision-making across ...
In a time when COAs are more nuanced, critical and complex than ever, researchers can turn to best practices to move forward ...
Sevabertinib, targeting HER2 and EGFR mutations, received FDA breakthrough designation for HER2+ NSCLC, showing a 59% overall ...
World-leading challenge study expertise helping deliver scalable, high-quality outpatient vaccine trials in healthy ...
The MajesTEC-9 trial showed a 40% reduced risk of death and a 71% reduced risk of disease progression or death with ...
Phase 3 SELVA study evaluating QTORIN™ rapamycin 3.9% anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic ...
Anthropic has launched Claude for Healthcare, the latest generative AI company to customize its offerings for specific healthcare use cases across providers, payers and biotech. The AI startup, which ...
Atara Biotherapeutics (NASDAQ: ATRA) has developed Ebvallo (tabelecleucel), a novel second-line immunotherapy for Epstein–Barr virus–positive post-transplant lymphoproliferative disease (EBV-PTLD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback